- Report
- October 2025
- 182 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 188 Pages
Global
From €3153EUR$3,545USD£2,740GBP
€3504EUR$3,939USD£3,044GBP
- Report
- August 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- August 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,470GBP
- Report
- July 2025
- 180 Pages
Global
From €3201EUR$3,599USD£2,781GBP
- Report
- May 2025
- 72 Pages
Global
From €3500EUR$4,215USD£3,147GBP
- Report
- May 2023
- 292 Pages
Global
From €3202EUR$3,600USD£2,782GBP
- Report
- October 2025
- 50 Pages
Global
From €2357EUR$2,650USD£2,048GBP
Enrofloxacin is an antibiotic used in animal pharmaceuticals to treat a variety of bacterial infections. It is a fluoroquinolone, a type of synthetic antibiotic, and is used to treat infections in dogs, cats, horses, and other animals. Enrofloxacin is available in both injectable and oral forms, and is often used to treat respiratory, urinary, and gastrointestinal infections. It is also used to treat skin and soft tissue infections, as well as certain types of bacterial infections.
Enrofloxacin is generally well-tolerated by animals, and is considered to be a safe and effective treatment for bacterial infections. However, it is important to follow the instructions of a veterinarian when administering the drug, as it can cause serious side effects if not used properly.
Some companies that produce enrofloxacin include Bayer, Merck, Zoetis, Elanco, and Norbrook. Show Less Read more